Non-Medical Switching

Hero background

Health plans and policymakers may think it’s “no big deal” to switch people from the medications that keep their hearts healthy. They couldn’t be more wrong. That’s the burden of non-medical switching. 


Drug Price Negotiation Program

Studies suggest that health plans that administer Part D will increase financial exposure because of the reforms Congress implemented in 2022 that were meant to help patients. PBMs and their health plans are already blunting their financial impact by increasing average out-of-pocket costs by 32% in 2025 for medications that have had their price capped by Medicare.

Blogs

When Insurers Push Heart Patients off Their Medication

Finding the right medication for a heart condition can be tricky and time-consuming. So what happens when the insurance company then compels patients to switch?
Learn More

CVS Caremark "Switch" Puts Heart Patients at Risk

Millions of people susceptible to blood clots started 2022 at higher risk of stroke. Why? Their health plan’s pharmacy benefit manager decided to stop covering their blood thinner.
Learn More

Insurers are Deepening America's Cardiovascular Epidemic

Every new COVID-19 variant reignites fears of untimely deaths. Yet heart disease continues to kill more people than the coronavirus every single year.
Learn More

Letters & Statements

Non-Medical Switching Poses a Danger to Medicare Patients

Letter to CMS on the need to monitor non-medical switching protocols to protect patient access.
Learn More

Papers

Non-Medical Switching and Cardiovascular Health

As Americans come to terms with the more than half a million victims of COVID-19, many overlook a startling fact. Cardiovascular disease exacts an even larger toll on public health every year.
Read More

Videos

Non-Medical Switching: No Big Deal?

When your health plan switches your heart medication, it IS a big deal.
Watch Now